The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the …

P Lancellotti, PA Pellikka, W Budts… - European Heart …, 2016 - academic.oup.com
A unique and highly versatile technique, stress echocardiography (SE) is increasingly
recognized for its utility in the evaluation of non-ischaemic heart disease. SE allows for …

Management of asymptomatic severe aortic stenosis: evolving concepts in timing of valve replacement

BR Lindman, MR Dweck, P Lancellotti… - Cardiovascular …, 2020 - jacc.org
New insights into the pathophysiology and natural history of patients with aortic stenosis,
coupled with advances in diagnostic imaging and the dramatic evolution of transcatheter …

2016 focused update: clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations

M Guazzi, R Arena, M Halle, MF Piepoli, J Myers… - Circulation, 2016 - Am Heart Assoc
In the past several decades, cardiopulmonary exercise testing (CPX) has seen an
exponential increase in its evidence base. The growing volume of evidence in support of …

Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized …

J Bermejo, R Yotti, R García-Orta… - European Heart …, 2018 - academic.oup.com
Aims We aimed to determine whether treatment with sildenafil improves outcomes of
patients with persistent pulmonary hypertension (PH) after correction of valvular heart …

Nrf2 in health and disease: current and future clinical implications

O Al-Sawaf, T Clarner, A Fragoulis, YW Kan… - Clinical …, 2015 - portlandpress.com
The transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) is a major regulator
of oxidative stress defence in the human body. As Nrf2 regulates the expression of a large …

Pulmonary hypertension in aortic and mitral valve disease

MT Maeder, L Weber, M Buser, M Gerhard… - Frontiers in …, 2018 - frontiersin.org
In patients with aortic and/or mitral valve disease the presence of pulmonary hypertension
(PH) indicates a decompensated state of the disease with left ventricular and left atrial …

Acute heart failure and valvular heart disease: A scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European …

O Chioncel, M Adamo, M Nikolaou… - European Journal of …, 2023 - Wiley Online Library
Acute heart failure (AHF) represents a broad spectrum of disease states, resulting from the
interaction between an acute precipitant and a patient's underlying cardiac substrate and …

Implantable hemodynamic monitors improve survival in patients with heart failure and reduced ejection fraction

JA Lindenfeld, MR Costanzo, MR Zile… - Journal of the American …, 2024 - jacc.org
Background Trials evaluating implantable hemodynamic monitors to manage patients with
heart failure (HF) have shown reductions in HF hospitalizations but not mortality. Prior meta …

Impact of periprocedural pulmonary hypertension on outcomes after transcatheter aortic valve replacement

J Miyamoto, Y Ohno, N Kamioka, Y Ikari… - Journal of the American …, 2022 - jacc.org
Background There are limited data on the prognostic impact of periprocedural pulmonary
hypertension (PH) after transcatheter aortic valve replacement (TAVR). Objectives The aim …

Exercise-induced signaling pathways to counteracting cardiac apoptotic processes

HA Pahlavani - Frontiers in Cell and Developmental Biology, 2022 - frontiersin.org
Cardiovascular diseases are the most common cause of death in the world. One of the major
causes of cardiac death is excessive apoptosis. However, multiple pathways through …